Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,229 | 2,869 | 5,584 | 8,354 | 1,671 |
| Marketable Securities | N/A | N/A | N/A | N/A | 511 |
| TOTAL | $8,102 | $3,456 | $5,689 | $8,583 | $2,532 |
| Non-Current Assets | |||||
| PPE Net | 11 | 12 | 7 | 7 | 6 |
| Other Non-Current Assets | 243 | 270 | 296 | 322 | 347 |
| TOTAL | $254 | $282 | $303 | $328 | $353 |
| Total Assets | $8,356 | $3,738 | $5,992 | $8,912 | $2,885 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 919 | 1,287 | 860 | 776 | 792 |
| Accrued Expenses | 435 | 461 | 704 | 685 | 383 |
| TOTAL | $1,446 | $1,976 | $1,564 | $1,461 | $1,175 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 126 | 155 | 184 | 212 | 239 |
| TOTAL | $126 | $155 | $184 | $212 | $239 |
| Total Liabilities | $1,572 | $2,131 | $1,748 | $1,673 | $1,414 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16 | 16 | 16 | 16 | 16 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -284,077 | -281,216 | -278,494 | -275,284 | -271,485 |
| TOTAL | $6,784 | $1,606 | $4,245 | $7,239 | $1,471 |
| Total Liabilities And Equity | $8,356 | $3,738 | $5,992 | $8,912 | $2,885 |